Prescription RequiredAcaone Acalabrutinib 100 mg Capsules are an oral targeted therapy used to treat chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL). Acalabrutinib works by blocking the Bruton’s tyrosine kinase (BTK) enzyme, which helps prevent the growth and spread of cancer cells, thereby slowing disease progression and improving treatment outcomes.
| Generic Name | Acalabrutinib |
| Manufacturer | MSN |
| Packing | 30 Capsules |
| Prescribed For | Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries. |
Disclaimer
This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.
Dr. Abhinav Narang holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. His interests include anticancer therapies, monitoring treatment response, managing treatment-related side effects and providing supportive care throughout the patient’s treatment journey.
